Cargando…

Fetuin-A and risk of diabetes-related vascular complications: a prospective study

BACKGROUND: Fetuin-A is a hepatokine which has the capacity to prevent vascular calcification. Moreover, it is linked to the induction of metabolic dysfunction, insulin resistance and associated with increased risk of diabetes. It has not been clarified whether fetuin-A associates with risk of vascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birukov, Anna, Polemiti, Elli, Jäger, Susanne, Stefan, Norbert, Schulze, Matthias B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742328/ https://www.ncbi.nlm.nih.gov/pubmed/34998417 http://dx.doi.org/10.1186/s12933-021-01439-8

Ejemplares similares

Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study
por: Birukov, Anna, et al.
Publicado: (2021)

Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications
por: Birukov, Anna, et al.
Publicado: (2020)

BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study
por: Polemiti, Elli, et al.
Publicado: (2021)

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
por: Stefan, Norbert, et al.
Publicado: (2008)

Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy
por: Roos, Marcel, et al.
Publicado: (2010)

Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies
por: Stefan, Norbert, et al.
Publicado: (2014)

Effect of Fetuin-A and oxidative stress on the occurrence of unexplained infertility
por: Taşkan, Tuba, et al.
Publicado: (2023)

Fetuin B may be a potential marker for predicting maternal and neonatal outcomes in intrahepatic cholestasis: Prospective case-control study
por: Begum, Jasmina, et al.
Publicado: (2023)

Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients
por: Chen, Hung Yuan, et al.
Publicado: (2016)

Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy
por: Zhao, Chunming, et al.
Publicado: (2015)

Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development
Publicado: (1975)

Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study
por: Ford, Earl S, et al.
Publicado: (2008)

An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total Mortality
por: Zembic, Anika, et al.
Publicado: (2021)

Global trend of diabetes mortality attributed to vascular complications, 2000–2016
por: Ling, Wei, et al.
Publicado: (2020)

FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation
por: Mattinzoli, Deborah, et al.
Publicado: (2019)

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
por: Hennige, Anita M., et al.
Publicado: (2008)

Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study
por: Jäger, Susanne, et al.
Publicado: (2015)

Fetuin-A and fetal growth in gestational diabetes mellitus
por: Wang, Wen-Juan, et al.
Publicado: (2020)

Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort
por: Slieker, Roderick C., et al.
Publicado: (2019)

Fetuin-A and vascular calcification in Indian end-stage renal disease population
por: Mann, A., et al.
Publicado: (2016)

Vascular Calcification Is Associated with Fetuin-A and Cortical Bone Porosity in Stone Formers
por: Rodrigues, Fernanda Guedes, et al.
Publicado: (2022)

Fetuin‐A aggravates lipotoxicity in podocytes via interleukin‐1 signaling
por: Orellana, Jana M., et al.
Publicado: (2017)

The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells
por: Gerst, Felicia, et al.
Publicado: (2021)

Breast-feeding and maternal risk of type 2 diabetes: a prospective study and meta-analysis
por: Jäger, Susanne, et al.
Publicado: (2014)

Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: a prospective cohort study
por: Ying, Ariel Fangting, et al.
Publicado: (2022)

Nanobacteria Are Mineralo Fetuin Complexes
por: Raoult, Didier, et al.
Publicado: (2008)

Fetuin-A levels in hyperthyroidism
por: Pamuk, Barış Onder, et al.
Publicado: (2013)

Fetuin-A is also an adipokine
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Fetuin-A and Albumin Alter Cytotoxic Effects of Calcium Phosphate Nanoparticles on Human Vascular Smooth Muscle Cells
por: Dautova, Yana, et al.
Publicado: (2014)

Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity
por: Nagao, Hirofumi, et al.
Publicado: (2013)

Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
por: Ceriello, Antonio, et al.
Publicado: (2021)

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes
por: Kannenkeril, Dennis, et al.
Publicado: (2018)

Distribution and Economic Burden of Diabetes-Related Microvascular Complications in Türkiye
por: Birinci, Şuayıp, et al.
Publicado: (2023)

Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.
por: Sun, Qi, et al.
Publicado: (2013)

Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)
por: Kosiborod, Mikhail, et al.
Publicado: (2018)

Association of the human gut microbiota with vascular stiffness
por: Cuadrat, Rafael R. C., et al.
Publicado: (2023)

Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes
por: Ochieng, Josiah, et al.
Publicado: (2018)

Fetuin-A as a Marker of NAFLD
por: Dharmalingam, Mala, et al.
Publicado: (2021)

How does the macroenvironment influence brain and behaviour – a review of current status and future perspectives
por: Polemiti, Elli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oheghp6v70nb96a7eaot6iphoj